Long-term results of the international adjuvant lung cancer trial evaluating adjuvant Cisplatin-based chemotherapy in resected lung cancer.
暂无分享,去创建一个
Bengt Bergman | Rodrigo Arriagada | Robert Pirker | R. Arriagada | J. Pignon | R. Pirker | A. Dunant | T. le Chevalier | C. Le Péchoux | B. Bergman | M. Chabowski | Cécile Le Péchoux | Jean-Pierre Pignon | Thierry Le Chevalier | Ariane Dunant | D. Grunenwald | Mariusz Chabowski | Dominique Grunenwald | Miroslaw Kozlowski | Maria-Izabel Sathler Pinel | Michèle Tarayre | M. Kozłowski | M. Tarayre | M. S. Pinel
[1] U. Chaudhary,et al. Long-Term Complications of Chemotherapy for Germ Cell Tumours , 2012, Drugs.
[2] H. Choy,et al. Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] J. Pignon,et al. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[4] S. Fosså,et al. OECI Workshop on late side-effects of cancer treatments. , 2009, European journal of cancer.
[5] David J Sugarbaker,et al. Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] Lesley Seymour,et al. Pooled analysis of the effect of age on adjuvant cisplatin-based chemotherapy for completely resected non-small-cell lung cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] Richard J Stephens,et al. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] L. Stewart,et al. C3-05: Chemotherapy (CT) in addition to surgery or surgery plus radiotherapy (RT) in non-small cell lung cancer (NSCLC): Two meta-analyses using individual patient data (IPD) from randomised controlled trials (RCTs) , 2007 .
[9] P. Hall,et al. Noncancer causes of death in survivors of testicular cancer. , 2007, Journal of the National Cancer Institute.
[10] J. Pignon,et al. Adjuvant Therapy for Early Lung Cancer: Reflections and Perspectives , 2006 .
[11] Elisabeth Brambilla,et al. DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy. , 2006, The New England journal of medicine.
[12] Julio Astudillo,et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial. , 2006, The Lancet. Oncology.
[13] R. Collins,et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.
[14] F. Shepherd,et al. Adjuvant Chemotherapy for Early-Stage Non-small Cell Lung Cancer. , 2005, Chest.
[15] M. Rabin,et al. Patient Subsets Benefiting from Adjuvant Therapy Following Surgical Resection of Non–Small Cell Lung Cancer , 2005, Clinical Cancer Research.
[16] Robert Livingston,et al. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. , 2005, The New England journal of medicine.
[17] Y Wang,et al. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.
[18] R. Stahel,et al. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of small-cell lung cancer (SCLC). , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.
[19] R. Schilsky,et al. Randomized Clinical Trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in Stage IB Non-Small Cell Lung Cancer (NSCLC): Report of Cancer and Leukemia Group B (CALGB) Protocol 9633. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] M. Parmar,et al. Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial. , 2004, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[21] Bengt Bergman,et al. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. , 2004, The New England journal of medicine.
[22] S. Fosså. Long-term sequelae after cancer therapy--survivorship after treatment for testicular cancer. , 2004, Acta oncologica.
[23] R. Arriagada,et al. Prophylactic cranial irradiation in high-risk non-small cell lung cancer patients. , 2003, Lung cancer.
[24] G. Giaccone,et al. Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell Lung cancer. , 2003, Journal of the National Cancer Institute.
[25] R. Stahel,et al. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of non-small-cell lung cancer (NSCLC). , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.
[26] S. Adak,et al. A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology Group. , 2000, The New England journal of medicine.
[27] J. Bourhis,et al. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data , 2000, The Lancet.
[28] S. Burdett,et al. Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials , 1998, The Lancet.
[29] M Schemper,et al. A note on quantifying follow-up in studies of failure time. , 1996, Controlled clinical trials.
[30] O. Brodin,et al. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials , 1995 .
[31] P. Sterk,et al. Long-term effects of chemotherapy in patients with testicular cancer. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] M. Wartelle,et al. PIGAS - An Interactive Statistical Database Management System , 1983, SSDBM.
[33] D. Cox. Regression Models and Life-Tables , 1972 .